Labcorp (LH)
NYSE: LH · Health Care Services · Burlington, NC
Our rating: Neutral
Neutral reaffirmed at $355.59, moderate conviction, November 2, 2026.
Breaks if: The Neutral call turns Positive if trailing free cash flow reaches $1.7B within four reported quarters — roughly a 42% step-up from the current $1.2B — validating a genuine acceleration in earnings power that reframes the 34x multiple. It turns Cautious if revenue growth decelerates below 3% for two consecutive quarters; at this multiple, a stalling top line leaves the stock with no valuation support.
Key figures
| Market value | $29.8B |
|---|---|
| Revenue, last 12 months | $14.6B |
| Net income, last 12 months | $1.0B |
| Free cash flow, last 12 months | $1.3B |
| Price to earnings | 29.7× |
| Free cash flow yield | 4.3% |
| Dividend yield | 0.8% |
| Operating margin | 10.3% |
| Return on equity | 11.4% |
| Beta to the S&P 500 | 0.49 |
| Volatility, annualized | 24.2% |
Reported quarters
| Quarter ending | Revenue | Year on year | Earnings per share | Free cash flow |
|---|---|---|---|---|
| September 30, 2026 | $3.8B | 6.9% | $3.22 | $412M |
| June 30, 2026 | $3.7B | 5.8% | $3.64 | $314M |
| March 31, 2026 | $3.5B | 5.8% | $3.35 | $71M |
| December 31, 2025 | $3.5B | 5.6% | $1.98 | $490M |
| September 30, 2025 | $3.6B | 8.6% | $3.12 | $281M |
| June 30, 2025 | $3.5B | 9.5% | $2.84 | $543M |
| March 31, 2025 | $3.3B | 5.3% | $2.52 | −$108M |
| December 31, 2024 | $3.3B | 9.8% | $1.71 | $665M |
Three-model forecasts for the next quarter
Written November 21, 2026, before the report. Each settles from the SEC filing.
- Revenue for the quarter is at least $3.73B: Claude 82%, Gemini 95%, Mistral 95%
- Diluted earnings per share are at least $1.98: Claude 72%, Gemini 92%, Mistral 97%
- Free cash flow for the quarter is at least $0.49B: Claude 45%, Gemini 70%, Mistral 60%
11 ledger entries and 31 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.